AstraZeneca Unloads Four NDAs to ANI Pharmaceuticals in $46.5M Deal By Sam | December 28, 2017 ANI Phamaceuticals funded the acquisitions through a combination of cash and debt. Source: BioSpace Posted in BioPharma